HCW Biologics Inc. (HCWB:NASDAQ) closed at $1.17 on October 23, 2026, up 4.46% on the day. The stock trades 95.1% below its 52-week high of $23.94 and 7.3% above its 52-week low of $1.09. Over the past year, it lost 95.0%. HCW Biologics Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, HCWB closed higher on 82 days (33%). Its best day was May 15, 2026 (+262.02%) and its worst was March 23, 2026 (-29.91%). The stock moved 10% or more in a single session 44 times. It opened at least 5% above the previous day's high 4 times.
HCW Biologics Inc is a preclinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation and age-related diseases. It is developing HCW9218 as an injectable immunotherapeutic for patients with solid tumors.
Find more stocks like HCWB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.